Dionex Corporation Home

Extreme Throughput for Pre-Clinical Drug Development

RSLC and x2-Dual Provide Fast, Flexible Performance

Pharmaceutical drug discovery identifies, validates and optimizes drug candidates based on achieving a desired pharmacological activity. However, at this point, there is very little data on the New Chemical Entity’s (NCE) safety. Research in the pre-clinical drug development area allows us to understand much about the safety of the compound by investigating how a compound affects the body and how the body affects the compound. Performing both in-vitro and in-vivo studies, an over-arching safety profile is constructed. Clearly, creating this profile involves a very large number of highly sensitive analyses.

Dionex solutions, based on the UltiMate® RSLC and x2 Dual systems, have the sensitivity and throughput required to handle limited samples in large numbers.